Physician profile
Daniel L Morgan
NPI 1538209036
$1,345.50
in general payments reported to CMS, 2019-2025
21 companies · $226 in 2025
The $226 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $296 · 2021: $18.16 · 2022: $62.47 · 2023: $298 · 2024: $444 · 2025: $226.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $969.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $968.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $273.77 | 2021-2025 | Parietene Ds, Transorb, Chameleon |
| Tas Medical, INC. | $268.58 | 2024 | |
| Intuitive Surgical, INC. | $267.76 | 2019-2024 | |
| Janssen Biotech, INC. | $71.71 | 2023-2025 | Stelara, Tremfya |
| Mozarc Medical US LLC | $56.81 | 2023-2024 | Palindrome, Chameleon |
| Ethicon US, LLC | $55.10 | 2025 | Vistaseal, Ethicon, Enseal |
| Abbvie INC. | $52.21 | 2023-2025 | |
| Pacira Pharmaceuticals Incorporated | $41.10 | 2019-2025 | Exparel |
| Becton, Dickinson and Company | $30.87 | 2024 | Fluency Endovascular Stent Graft |
| Merck Sharp & Dohme LLC | $29.27 | 2023 | Bridion |
| Tela Bio, INC. | $27.12 | 2019 | |
| Surmodics, INC. | $26.24 | 2024 | Pounce Thrombectomy System, Pounce LP Thrombectomy, Pounce Venous Thrombectomy System |
| Cook Medical LLC | $22.42 | 2024 | Fusion |
| Kerecis Limited | $21.87 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Bard Peripheral Vascular, INC. | $18.21 | 2025 | Lutonix Drug Coated Balloon |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $16.72 | 2024 | |
| Conmed Corporation | $14.72 | 2025 | Airseal |
| Laminate Medical Technologies INC. | $14.30 | 2025 | Vasq |
| Teleflex LLC | $13.99 | 2024 | Titan Sgs |
| Phathom Pharmaceuticals, INC. | $13.13 | 2024 | Voquezna |
| Lemaitre Vascular, INC. | $9.60 | 2023 | Cardiocel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Morgan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.